Factors regulating strength and duration of STING signaling
调节 STING 信号强度和持续时间的因素
基本信息
- 批准号:10490901
- 负责人:
- 金额:$ 42.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-17 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAllelesAutoimmunityAutophagocytosisAutophagosomeBiochemicalBiologyCRISPR screenCell DeathCell modelCellsChronicClustered Regularly Interspaced Short Palindromic RepeatsDNADevelopmentEndosomesFactor AnalysisGenesGoalsGolgi ApparatusHereditary Spastic ParaplegiaHumanHuman PathologyIRF3 geneImmuneImmune systemImmunityInflammationInheritedInterferonsKnock-outKnowledgeLigandsLigationLysosomesMalignant NeoplasmsMediatingMitochondriaModelingMutateMutationNeuraxisNuclearOptical MethodsPathogenicityPathway interactionsPatternProcessProteinsProteomicsRegulationResolutionRoleSensorySignal TransductionSiteStimulator of Interferon GenesTBK1 geneTREX1 geneTestingTherapeuticTumor ImmunityUbiquitinationVaccinesVascular DiseasesVirusVirus DiseasesWorkdisease-causing mutationgenome-widehuman diseaseimmune activationimmune healthimprovedmutantmutation screeningneoplastic cellnovelnucleasepathogenpseudotoxoplasmosis syndromerecruitresponsesealsensortraffickingtumorubiquitin-protein ligase
项目摘要
DNA sensing by the cGAS-STING pathway is essential for recognizing pathogens, tumor cells, and mitochondrial
or nuclear DNA under certain conditions, leading to homeostatic responses, such as immune control of
pathogens and cancer. Under some conditions, such as loss of the nuclease TREX1, excess DNA triggers cGAS-
STING and causes a chronic inflammation (e.g., Aicardi Goutierès Syndrome, or a constitutively active STING
allele, causes SAVI, an inherited vasculopathy). Upon activation by its ligand, cGAMP, STING translocates from
ER → Golgi → endosomes where it signals through TBK1 and IRF3 to activate interferons, and is then degraded
via lysosomes. These trafficking patterns are central to STING’s function, and yet we lack knowledge of many of
the genes regulating these processes. To identify regulators of STING activity, trafficking and degradation, we
performed two genome-wide CRISPR knockout screens, as well as a proximity-ligation mediated proteomic
analysis, and a focused CRISPR screen. Studying the dozens of factors found, we made two significant
discoveries that provide the basis for this proposal. First, we found that ESCRT-dependent endosomal
microautophagy requires recognition of ubiquitinated STING on endosomes, and is critical for STING
degradation, autophagosome sealing and signaling regulation. Disruption of this pathway by a pathogenic
ESCRT subunit mutant (found in a human disease) leads to constitutive STING signaling at steady state.
Second, we uncovered a novel interaction of ER-localized STING with endosomal protein DNAJC13, leading to
restriction of STING ER exit and activation. Loss of DNAJC13 or disruption of ER-endosome contact sites
dramatically boosts STING activity. Having defined a model of STING ubiquitination controlling autophagy
resolution, and DNAJC13 restricting STING ER exit, we propose to further our understanding of this pathway by
studying the mechanisms underlying these processes, including identifying E3 ubiquitin ligases that modify
STING and induce ESCRT-dependent autophagy, and determining the impact of STING-induced endosomal
microautophagy on viral infections. We will also determine how DNAJC13 blocks STING activity by altering
STING trafficking. We will test the roles of DNAJC13 and ER-endosomal contacts in limiting STING activation
by restricting STING ER exit to the TGN. To define the biochemical mechanisms of STING interactions, we will
use deep mutational scanning to find motifs on STING that are responsible for interactions with DNAJC13 and
for the effects of DNAJC13 on STING trafficking, as well as motifs that control other aspects of STING localization
and signaling. Finally, we will study how mutations in genes involved in human pathologies that regulate STING
trafficking, impact inflammation and death of cells of the central nervous system. A better understanding of
STING trafficking, degradation and signaling will help us develop therapeutic approaches to dampen
autoimmunity or boost pathogen and tumor immunity.
CGAS-STING通路的DNA传感对于识别病原体、肿瘤细胞和线粒体是必不可少的
或核DNA在某些条件下,导致动态平衡反应,如免疫控制
病原体和癌症。在某些情况下,例如核酸酶TREX1的丢失,过量的DNA会触发cGAS-
刺痛并导致慢性炎症(例如,艾卡迪·古铁埃S综合征或结构性活动性刺痛
等位基因,导致SAVI,一种遗传性血管病变)。当被其配体cGAMP激活时,STING从
ER→高尔基体→内体,通过Tbk1和irf3发出信号激活干扰素,然后被降解
通过溶酶体。这些贩运模式是斯汀功能的核心,但我们对许多
控制这些过程的基因。为了确定诱捕活动、贩运和退化的监管机构,我们
进行了两次全基因组CRISPR基因敲除筛选,以及邻近连接介导的蛋白质组学研究
分析,以及聚焦的CRISPR屏幕。对发现的几十个因素进行研究后,我们得出了两个有意义的结论
为这一提议提供基础的发现。首先,我们发现ESCRT依赖的内体
微自噬需要识别内体上泛素化的刺痛,这是刺痛的关键。
降解、自噬小体封闭和信号调节。由致病因子引起的这一途径的中断
ESCRT亚单位突变(在人类疾病中发现)在稳定状态下导致结构性刺痛信号。
其次,我们发现了一种新的内质网定位的STING与内体蛋白DNAJC13的相互作用,导致
限制刺激性内质网退出和激活。DNAJC13丢失或内质网-内吞体接触点中断
极大地促进了人们的活动。定义了一种控制自噬的刺痛泛素化模型
决议和限制刺激性ER退出的DNAJC13,我们建议通过以下方式进一步了解这一途径
研究这些过程的机制,包括鉴定E3泛素连接酶
刺伤和诱导ESCRT依赖的自噬,以及确定刺伤诱导的内体的影响
病毒感染上的微自噬。我们还将确定DNAJC13如何通过更改
诱捕人口贩子。我们将测试DNAJC13和ER-内体接触在限制刺痛激活中的作用
通过将STINER出口限制在TGN。为了定义刺痛相互作用的生化机制,我们将
使用深度突变扫描寻找负责与DNAJC13和DNAJC13相互作用的STING基序
DNAJC13对STING贩运的影响,以及控制STING本地化的其他方面的基序
和信号。最后,我们将研究基因突变如何参与人类调节刺痛的病理过程。
贩运、影响中枢神经系统细胞的炎症和死亡。更好地理解
打击贩运、降解和信号传递将帮助我们开发治疗方法,以抑制
自身免疫力或增强病原体和肿瘤免疫力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nir Hacohen其他文献
Nir Hacohen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nir Hacohen', 18)}}的其他基金
Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries
使用大规模纳米抗体库开发癌症蛋白质组高度多重定量的方法
- 批准号:
10714023 - 财政年份:2023
- 资助金额:
$ 42.36万 - 项目类别:
Factors regulating strength and duration of STING signaling
调节 STING 信号强度和持续时间的因素
- 批准号:
10677771 - 财政年份:2021
- 资助金额:
$ 42.36万 - 项目类别:
Factors regulating strength and duration of STING signaling
调节 STING 信号强度和持续时间的因素
- 批准号:
10367563 - 财政年份:2021
- 资助金额:
$ 42.36万 - 项目类别:
Regulation, function and localization of monocytes in autoimmune tissues
自身免疫组织中单核细胞的调节、功能和定位
- 批准号:
10598099 - 财政年份:2021
- 资助金额:
$ 42.36万 - 项目类别:
Regulation, function and localization of monocytes in autoimmune tissues
自身免疫组织中单核细胞的调节、功能和定位
- 批准号:
10088789 - 财政年份:2021
- 资助金额:
$ 42.36万 - 项目类别:
Regulation, function and localization of monocytes in autoimmune tissues
自身免疫组织中单核细胞的调节、功能和定位
- 批准号:
10427146 - 财政年份:2021
- 资助金额:
$ 42.36万 - 项目类别:
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)
通过肾脏 RNA 检测实现精准医学 (PREMIERE)
- 批准号:
10242728 - 财政年份:2017
- 资助金额:
$ 42.36万 - 项目类别:
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)
通过肾脏 RNA 检测实现精准医学 (PREMIERE)
- 批准号:
9910974 - 财政年份:2017
- 资助金额:
$ 42.36万 - 项目类别:
Project 2: Genes required for dendritic cell responses to pathogens and T cells
项目2:树突状细胞对病原体和T细胞做出反应所需的基因
- 批准号:
10207350 - 财政年份:2017
- 资助金额:
$ 42.36万 - 项目类别:
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)
通过肾脏 RNA 检测实现精准医学 (PREMIERE)
- 批准号:
10703510 - 财政年份:2017
- 资助金额:
$ 42.36万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 42.36万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 42.36万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 42.36万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 42.36万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 42.36万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 42.36万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 42.36万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 42.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 42.36万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 42.36万 - 项目类别: